News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
Sensorion achieves key regulatory milestones for SENS-601 addressing GJB2-related hearing loss and discontinues SENS-501. Fast Track procedure granted by ANSM in France. Clinical trials planned in Canada and U.S. IND submission targeted by 2026 -
-
-
-
-